HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 132 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $192,000 | -13.1% | 21,681 | +23.8% | 0.00% | 0.0% |
Q2 2022 | $221,000 | -25.8% | 17,519 | +10.9% | 0.00% | 0.0% |
Q1 2022 | $298,000 | -47.1% | 15,795 | -3.0% | 0.00% | -50.0% |
Q4 2021 | $563,000 | -3.4% | 16,289 | +2.2% | 0.00% | 0.0% |
Q3 2021 | $583,000 | +11.0% | 15,943 | +19.1% | 0.00% | 0.0% |
Q2 2021 | $525,000 | +26.2% | 13,389 | -9.2% | 0.00% | 0.0% |
Q1 2021 | $416,000 | -10.7% | 14,751 | -6.7% | 0.00% | 0.0% |
Q4 2020 | $466,000 | 0.0% | 15,803 | +9.9% | 0.00% | 0.0% |
Q3 2020 | $466,000 | +31.6% | 14,379 | +11.7% | 0.00% | 0.0% |
Q2 2020 | $354,000 | +86.3% | 12,872 | +20.5% | 0.00% | +100.0% |
Q1 2020 | $190,000 | -53.4% | 10,686 | -34.3% | 0.00% | -50.0% |
Q4 2019 | $408,000 | +22.9% | 16,268 | -12.6% | 0.00% | 0.0% |
Q3 2019 | $332,000 | -38.7% | 18,606 | -24.5% | 0.00% | -33.3% |
Q2 2019 | $542,000 | -20.3% | 24,651 | +10.9% | 0.00% | -25.0% |
Q1 2019 | $680,000 | -56.4% | 22,229 | -67.0% | 0.00% | 0.0% |
Q4 2018 | $1,560,000 | – | 67,340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |